MetLife Investment Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374K | Hold |
39,718
| – | – | ﹤0.01% | 1815 |
|
|
2025
Q1 | $215K | Sell |
39,718
-784
| -2% | -$4.25K | ﹤0.01% | 2160 |
|
|
2024
Q4 | $302K | Buy |
40,502
+11,217
| +38% | +$83.6K | ﹤0.01% | 2070 |
|
|
2024
Q3 | $234K | Hold |
29,285
| – | – | ﹤0.01% | 2208 |
|
|
2024
Q2 | $255K | Buy |
29,285
+10,106
| +53% | +$87.9K | ﹤0.01% | 2097 |
|
|
2024
Q1 | $396K | Buy |
19,179
+5,206
| +37% | +$108K | ﹤0.01% | 1804 |
|
|
2023
Q4 | $323K | Hold |
13,973
| – | – | ﹤0.01% | 1949 |
|
|
2023
Q3 | $112K | Hold |
13,973
| – | – | ﹤0.01% | 2525 |
|
|
2023
Q2 | $122K | Buy |
+13,973
| New | +$122K | ﹤0.01% | 2569 |
|
|
2022
Q4 | – | Sell |
-12,835
| Closed | -$102K | – | 2834 |
|
|
2022
Q3 | $102K | Hold |
12,835
| – | – | ﹤0.01% | 2676 |
|
|
2022
Q2 | $101K | Hold |
12,835
| – | – | ﹤0.01% | 2710 |
|
|
2022
Q1 | $156K | Buy |
12,835
+4,582
| +56% | +$55.7K | ﹤0.01% | 2494 |
|
|
2021
Q4 | $101K | Buy |
+8,253
| New | +$101K | ﹤0.01% | 2403 |
|